Myths vs. Facts: Getting Ocrevus (ocrelizumab) Covered by Blue Cross Blue Shield in Washington
Answer Box: Getting Ocrevus Covered by Blue Cross Blue Shield in Washington
Eligibility: Ocrevus requires prior authorization from Blue Cross Blue Shield Washington plans. New requests effective March 10, 2025 require failure of 2+ disease-modifying therapies including natalizumab for relapsing MS, or confirmed primary progressive MS diagnosis under age 55.